HPV testing 1

• OC 01-01 • European HPV DNA test external quality assurance scheme (EHEQAS) See abstract > P. Pavlos Neophytou • OC 01-02 • Validation of HPV DNA array genotyping assay with cervical cancer samples See abstract > A. Aleksandra Pesic • OC 01-03 • INTER-LABORATORY REPRODUCIBILITY OF THE COBAS 4800 HPV TEST IN CERVICAL CANCER SCREENING IN NORWAY See abstract > I. Irene Kraus Christiansen • OC 01-04 • Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening See abstract > D. Davy Vanden Broeck • OC 01-05 • HPV Test of Cure (TOC) for treated CIN in 14,000 women - An analysis of 3½ years’ national data from Scotland See abstract > T. Timothy Palmer • OC 01-06 • Validity testing of cervical samples intended for oncoprotein-base cervical cancer screening See abstract > M. Melanie Thiessen • OC 01-07 • Performance evaluation of Papilloplex(TM) HR-HPV kit – a novel multiplexing assay for genotyping all 14 HR HPV types in a single closed tube real-time PCR reaction See abstract > D. Devarshi Kapadia • OC 01-08 • Optimizing point-of-care HPV testing for cervical cancer prevention in South Africa See abstract > L. Louise Kuhn • OC 01-09 • A new Elisa-based tool for detection of high-risk HPV E7 proteins in cervical samples See abstract > I. Isabel Koch • OC 01-11 • Combined Cytology, HPV E6, E7 mRNA, and Cell Cycle in an Automated, High Throughput Image Cytometer See abstract > B. Bruce Patterson • OC 01-10 • Genome analysis of high risk HPV integration using molecular combing in cervical lesions: the IDAHO study See abstract > C. Christine Clavel